Comparative Safety Study of New Sinecort Formulation Versus Positive Control

NCT00885937 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Dexpanthenol (Sinecort, BAY81-2996)
DRUG: Positive control, Na-laurylsulfat-solution
DEVICE: Untreated skin under application chamber

Sponsor

Bayer